Author

Juha O. Rinne

Institutions: University of Turku, Turku University Hospital, Turku PET Centre, Swiss Epilepsy Center

Observed institutions: University of Turku, Turku University Hospital, Turku PET Centre, Swiss Epilepsy Center

OpenAlex ID: A5113665533

A Phase II Trial of Tideglusib in Alzheimer's Disease

2015 · Simon Lovestone, for the ARGO investigators, et al. · Journal of Alzheimer s Disease · 562

Cognitive Impairment and the Brain Dopaminergic System in Parkinson Disease

2000 · Juha O. Rinne, Raija Portin, et al. · Archives of Neurology · 343

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

1989 · Juha O. Rinne, Jaana Rummukainen Mlic, et al. · Annals of Neurology · 330

Age-dependent decline in human brain dopamine D1 and D2 receptors

1990 · Juha O. Rinne, Pirkko Lönnberg, et al. · Brain Research · 191

PET examination of the monoamine transporter with [11c]β‐CIT and [11c]β‐CFT in early parkinson's disease

1995 · Juha O. Rinne, Arto Laihinen, et al. · Synapse · 70

Picture naming deficits in vascular dementia and Alzheimer's disease

1997 · Matti Laine, Elina Vuorinen, et al. · Journal of Clinical and Experimental Neuropsychology · 58

[18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

2001 · Juha O. Rinne, Elina Nurmi, et al. · Synapse · 57

Perceptual priming in Alzheimer's and Parkinson's diseases

1996 · Mika Koivisto, Raija Portin, et al. · Neuropsychologia · 48

Works count: 8

Citation count: 1,659

H-index: 8

I10-index: 8